State Street
MBIO icon

State Street’s Mustang Bio MBIO Stock Holding History

State Street’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-320
Closed -$2.83K – 4305
2024
Q4 		$2.83K Hold
320
– – ﹤0.01% 4295
2024
Q3 		$3.77K Hold
320
– – ﹤0.01% 4286
2024
Q2 		$7.58K Hold
320
– – ﹤0.01% 4335
2024
Q1 		$16.7K Hold
320
– – ﹤0.01% 4301
2023
Q4 		$21.6K Hold
320
– – ﹤0.01% 4333
2023
Q3 		$32.8K Hold
320
– – ﹤0.01% 4367
2023
Q2 		$99.5K Hold
320
– – ﹤0.01% 4241
2023
Q1 		$88.1K Hold
320
– – ﹤0.01% 4359
2022
Q4 		$94.9K Hold
320
– – ﹤0.01% 4385
2022
Q3 		$113K Hold
320
– – ﹤0.01% 4422
2022
Q2 		$141K Sell
320
-1,618
-83% -$896K ﹤0.01% 4359
2022
Q1 		$1.47M Sell
1,938
-3
-0.2% -$2.46K ﹤0.01% 3675
2021
Q4 		$2.42M Buy
1,941
+36
+2% +$58.1K ﹤0.01% 3582
2021
Q3 		$3.84M Buy
1,905
+557
+41% +$1.2M ﹤0.01% 3365
2021
Q2 		$3.36M Buy
1,348
+409
+44% +$1M ﹤0.01% 3414
2021
Q1 		$2.34M Buy
939
+72
+8% +$214K ﹤0.01% 3374
2020
Q4 		$2.46M Buy
867
+168
+24% +$402K ﹤0.01% 3279
2020
Q3 		$1.65M Buy
699
+34
+5% +$83.8K ﹤0.01% 3274
2020
Q2 		$1.59M Buy
665
+9
+1% +$21K ﹤0.01% 3273
2020
Q1 		$1.32M Sell
656
-3
-0.5% -$7.69K ﹤0.01% 3235
2019
Q4 		$2.02M Buy
659
+22
+3% +$50.4K ﹤0.01% 3244
2019
Q3 		$1.56M Buy
637
+212
+50% +$580K ﹤0.01% 3293
2019
Q2 		$1.17M Buy
425
+124
+41% +$354K ﹤0.01% 3394
2019
Q1 		$769K Buy
301
+1
+0.3% +$2.83K ﹤0.01% 3389
2018
Q4 		$661K Sell
300
-24
-7% -$73K ﹤0.01% 3403
2018
Q3 		$1.45M Buy
324
+22
+7% +$110K ﹤0.01% 3339
2018
Q2 		$1.56M Buy
+302
New +$1.91M ﹤0.01% 3338

Other funds holding MBIO

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street's MBIO Position: Q1 2025 in Review

State Street sold out of Mustang Bio (MBIO) in Q1 2025, closing a stake of 320 shares — an estimated $2.83K sold.

State Street first reported a position in MBIO in Q2 2018 and held it in 27 quarters. The position peaked at $3.84M in Q3 2021. 16 funds tracked by Wall St. Rank hold MBIO as of Q1 2025.

  • State Street reported no remaining Mustang Bio position as of Q1 2025 after selling out during the quarter.
  • State Street sold 320 Mustang Bio shares in Q1 2025, an estimated $2.83K.
  • State Street first reported a position in Mustang Bio in Q2 2018 and held it in 27 quarters.
  • State Street's Mustang Bio position peaked at $3.84M in Q3 2021.
  • 16 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2025.

Based on State Street's 13F filing for Q1 2025, filed 15 May 2025.